Clinical Trials Browser

Phase 2/3 × Extensive Stage Lung Small Cell Carcinoma × Magnetic Resonance Spectroscopy × Clear all

NCT04402788 2026-03-18

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Phase 2/3 Recruiting

Extensive Stage Lung Small Cell Carcinoma